# Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis

> **NCT02722642** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Regend Therapeutics** · enrollment: 20 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **BIOLOGICAL:** Bronchial basal cells

## Key facts

- **NCT ID:** NCT02722642
- **Lead sponsor:** Regend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02722642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02722642, "Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02722642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*